AVE 16.7% 0.3¢ avecho biotechnology limited

Rereading the Newsletter, two strong negatives(?) stand out, not...

  1. 379 Posts.
    Rereading the Newsletter, two strong negatives(?) stand out, not I think yet commented on:

    - unsurprisingly, the page on cosmetics is just an embarrassed commentary on failure (heavily promoted, too, as unfortunately had to be noted). Little future hope held out

    - more intriguingly and importantly, absolutely no mention of management succession. Expectation of a further new Director(s) but nothing re the key appointment - a new CEO. Rosen can't realistically go on much longer & they were certainly trying to find someone. Any long term (perhaps even medium term, ie. beyond mid 2015?) independent future for POH must crucially depend on managing to attract a credible successor. The next few months are clearly mapped out in the Newsletter. Thereafter....??
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(16.7%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $4.997K 1.832M

Buyers (Bids)

No. Vol. Price($)
63 101066526 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 21372825 7
View Market Depth
Last trade - 14.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.